Cargando…

Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile

Detalles Bibliográficos
Autor principal:	Carbillon, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504948/ https://www.ncbi.nlm.nih.gov/pubmed/23093230 http://dx.doi.org/10.1038/bjc.2012.487

Ejemplares similares

The incorporation of telehealth in high-risk pregnancy follow-up needs tailored optimized care scheduled in a strict care protocol
por: Carbillon, Lionel, et al.
Publicado: (2021)

Comment on: ‘Hypertensive diseases in pregnancy and breast cancer risk'
por: Cirillo, Piera M, et al.
Publicado: (2016)

COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women
por: Carbillon, Lionel, et al.
Publicado: (2021)

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

High second‐trimester uterine artery impedance correlates to maternal vascular malperfusion and related‐complications
por: Carbillon, Lionel, et al.
Publicado: (2022)

Is the maternal risk of pregnancy acceptable in patients with moderate pulmonary hypertension?
por: Rashidi, Farid, et al.
Publicado: (2021)

Blood pressure lowering in pregnancy
por: Sobieraj, Piotr
Publicado: (2021)

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
por: Roviello, Giandomenico, et al.
Publicado: (2021)

Association of Maternal Antiangiogenic Profile at Birth With Early Postnatal Loss of Microvascular Density in Offspring of Hypertensive Pregnancies
por: Yu, Grace Z., et al.
Publicado: (2016)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Anaesthesiologist's Tension- Lower Body Hypertension in Coarctation
por: Joshi, Reena Khantwal, et al.
Publicado: (2023)

Maternal pregnancy hormone profiles in areas with a different incidence of breast cancer
por: Akhmedkhanov, A A, et al.
Publicado: (2000)

Health education for the prevention of hypertensive disorders of pregnancy
por: dos Santos, Gustavo Gonçalves
Publicado: (2020)

Are pregnancy-associated hypertensive disorders so sweet?
por: Thomopoulos, Costas, et al.
Publicado: (2022)

Maternal pregnancy hormone profiles in areas with a different incidence of breast cancer – reply
por: Lipworth1, L, et al.
Publicado: (2000)

In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
por: Yuan, Yuan, et al.
Publicado: (2020)

Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
por: Fernandes, Timothy M., et al.
Publicado: (2020)

Hypertensive disorders of pregnancy and subsequent risk of Alzheimer's disease and other dementias
por: Schliep, Karen C., et al.
Publicado: (2023)

Subhyaloid hemorrhage as the presenting sign of pregnancy-induced hypertension
por: Natesh, Sribhargava, et al.
Publicado: (2009)

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
por: Caminha, Raquel D’Aquino Garcia, et al.
Publicado: (2019)

Effect of administering subsequent immune checkpoint inhibition in cancer patients with prior COVID-19 infection
por: Bi, Jianping, et al.
Publicado: (2021)

Cytomegalovirus proteins, maternal pregnancy cytokines, and their impact on neonatal immune cytokine profiles and acute lymphoblastic leukemogenesis in children
por: Wiemels, Joseph L., et al.
Publicado: (2022)

Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)

Antiangiogenic therapy in breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Pregnancy and immune thrombocytopenia: New trends
por: Yavaşoğlu, İrfan, et al.
Publicado: (2020)

Pre-eclampsia in pregnancy and subsequent risk for breast cancer
por: Vatten, L J, et al.
Publicado: (2002)

BIA-ALCL: Comparing the Risk Profiles of Smooth and Textured Breast Implants
por: Swanson, Eric
Publicado: (2023)

Diazoxide for Lowering Insulin Levels in Breast Cancer Patients
por: Fink, Michael K., et al.
Publicado: (2017)

Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”
por: Horn, Evelyn, et al.
Publicado: (2020)

Snoopy Breast and Double Bubble Have Much in Common
por: Borovikova, Anna, et al.
Publicado: (2016)

Bacterial corneal ulcer associated with common variable immune deficiency
por: Tsui, Edmund, et al.
Publicado: (2016)

Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months
por: Breathnach, Aodhán Seán, et al.
Publicado: (2021)

Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy
por: Tano, Sho, et al.
Publicado: (2021)

Modulation of Immunity by Antiangiogenic Molecules in Cancer
por: Terme, Magali, et al.
Publicado: (2012)

Introduction of Diphtheria Component Addition in Immunization During Pregnancy
por: Mukhida, Sahjid, et al.
Publicado: (2023)

Absence of the Labiomental Groove: A Common but Preventable Unpleasant Aesthetic Problem of the Lower Lip-Chin Burn Reconstruction
por: Mohammadi, Ali Akbar, et al.
Publicado: (2017)

Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing
por: Park, Hee Sue, et al.
Publicado: (2022)

Hypertension and tachycardia following high spinal anaesthesia during lower segment caesarean section: An unusual presentation
por: Chatterjee, Protiti, et al.
Publicado: (2022)

Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
por: Argyriou, Konstantinos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4gva83olkqo5msbl2huu75u9tq